tm logo
Trademark Search
CIRCLE WITH DIAGONAL LINE DESIGN
CIRCLE WITH DIAGONAL LINE DESIGN
ADVERTISED

on 08 Nov 2024

Last Applicant/ Owned by

MERCK SHARP & DOHME LLC

126 East Lincoln Ave.P.O. Box 2000Rahway, NJ 07065

US

Serial Number

2061361 filed on 02th Nov 2020

Registration Number

TMA1268188 registered on 08th Nov 2024

Registration expiry Date

08th Nov 2034

Correspondent Address

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

CIRCLE WITH DIAGONAL LINE DESIGN

Vienna Information


26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 7 . 4

Circles or ellipses with lines (except 26.7.3)Cercles ou ellipses avec lignes (excepté 26.7.3)

Trademark usage description

pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the prevention and treatment of bone, c Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for use in Oncology; Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-infectives, anti inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2061361

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 21st Aug 2024
Advertised
Submitted for opposition 26
on 26th Jul 2024
Approved
Submitted for opposition 27
on 26th Jul 2024
Approval Notice Sent
Submitted for opposition 22
on 18th Jul 2024
Search Recorded
Submitted for opposition 48
on 15th Mar 2024
Agent Changed
Submitted for opposition 135
on 10th Aug 2022
Amendment to Application
Submitted for opposition 287
on 04th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 02th Nov 2020
Filed
Submitted for opposition 1
on 02th Nov 2020
Created
Submitted for opposition 31
on 02th Nov 2020
Formalized